Literature DB >> 23242846

Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor).

J R Izbicki1, T Y Tsui, B A Bohn, M Bockhorn.   

Abstract

BACKGROUND: Surgical resection represents the only potentially curative treatment for hilar cholangicarcinoma. Because of the aggressive nature and the absence of effective adjuvant therapy treatment remains still a challenge. DISCUSSION: This manuscript reviews management of hilar cholangiocarcinoma with a focus on operative strategy.

Entities:  

Mesh：

Year:  2012        PMID： 23242846     DOI： 10.1007/s11605-012-2109-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


  12 in total

1.  ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES.

Authors:  G KLATSKIN
Journal:  Am J Med       Date:  1965-02       Impact factor: 4.965

2.  Sclerosing carcinoma of the major intrahepatic bile ducts.

Authors:  W A ALTEMEIER; E A GALL; M M ZINNINGER; P I HOXWORTH
Journal:  AMA Arch Surg       Date:  1957-09

Review 3.  Palliative management of hilar cholangiocarcinoma.

Authors:  D Singhal; T M van Gulik; D J Gouma
Journal:  Surg Oncol       Date:  2005-08       Impact factor: 3.279

Review 4.  Controversies in the use of portal vein embolization.

Authors:  Thomas M van Gulik; Jacomina W van den Esschert; Wilmar de Graaf; Krijn P van Lienden; Olivier R C Busch; Michal Heger; Otto M van Delden; Johan S Laméris; Dirk J Gouma
Journal:  Dig Surg       Date:  2009-02-12       Impact factor: 2.588

5.  Extended resections for hilar cholangiocarcinoma.

Authors:  P Neuhaus; S Jonas; W O Bechstein; R Lohmann; C Radke; N Kling; C Wex; H Lobeck; R Hintze
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

6.  Preoperative portal vein embolization for extended hepatectomy.

Authors:  Alan W Hemming; Alan I Reed; Richard J Howard; Shiro Fujita; Steven N Hochwald; James G Caridi; Irvin F Hawkins; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

7.  Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors.

Authors:  K Kubota; M Makuuchi; K Kusaka; T Kobayashi; K Miki; K Hasegawa; Y Harihara; T Takayama
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

8.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

9.  Cholangiocarcinoma: preoperative biliary drainage (Con).

Authors:  A Laurent; C Tayar; D Cherqui
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969
View more
  4 in total

1.  Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy.

Authors:  Gu-Wei Ji; Fei-Peng Zhu; Ke Wang; Chen-Yu Jiao; Zi-Cheng Shao; Xiang-Cheng Li
Journal:  J Gastrointest Surg       Date:  2017-02-06       Impact factor: 3.452

2.  Use of an autologous liver round ligament flap zeros postoperative bile leak after curative resection of hilar cholangiocarcinoma.

Authors:  Da-Xin Sun; Xiao-Dong Tan; Feng Gao; Jin Xu; Dong-Xu Cui; Xian-Wei Dai
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

3.  Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma.

Authors:  Ning Zeng; Haisu Tao; Chihua Fang; Yingfang Fan; Nan Xiang; Jian Yang; Wen Zhu; Jun Liu; Tianpei Guan; Cheng Fang; Fei Xiang
Journal:  World J Surg Oncol       Date:  2016-02-24       Impact factor: 2.754

4.  An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapy.

Authors:  Bruno Christian Köhler; Benjamin Goeppert; Nina Waldburger; Kai Schlamp; Peter Sauer; Dirk Jäger; Karl Heinz Weiss; Stephan Macher-Göppinger; Henning Schulze-Bergkamen; Peter Schirmacher; Christoph Springfeld
Journal:  Oncotarget       Date:  2018-04-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.